Skip to main content
. Author manuscript; available in PMC: 2014 Aug 13.
Published in final edited form as: Oncogene. 2013 Feb 18;33(7):899–908. doi: 10.1038/onc.2013.23

Figure 6.

Figure 6

(a) AsPC-1 soft agar growth or (b) HPAF-2 tumorsphere growth was measured in the context of vehicle (DMSO) or 0.1 μM IWP-2 treatment every 72 hours. (c) BAR-luciferase reporter assays at 48 hours in indicated cell lines with stable BAR-luciferase reporter and (d) HPAF tumorsphere growth were measured following treatment every 48 hours with 20 μg/ml anti-WNT7B antibody or matched isotype control antibody. * P<0.05, ** P<0.01.